Latest Prescription Drugs news
Triplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
posted September 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Semaglutide Reduces 10-Year Risk for T2D in Obese Persons
posted September 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
posted September 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Bebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
posted September 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
